Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The ...

DeepL, a leading global Language AI company, today unveiled its latest white paper, "The language revolution: how AI improves the way businesses communicate." Based on findings from a new DeepL survey ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Four Philly-area CEOs discuss how they got to their positions, who helped along the way, and tips for others forging the path forward.

EXCLUSIVE: BAFTA nominees George MacKay ( 1917) and Callum Turner ( Masters of the Air) have recently wrapped production in ...

LAUSANNE, Switzerland, Jan. 30, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced ...

LAUSANNE, Switzerland, Jan. 30, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced ...

One of Nashville's public companies is set to go private by Feb. 6. An amended deal offers shareholders 17% more compared to its previous offer. Revance Therapeutics has received an updated offer ...

Cayman Islands, January 29, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech ...

(NEXSTAR) — Content creator Bryce DeGroat claims that the colors in the Super Bowl logo can predict the teams that will reach the Super Bowl. While it might sound outlandish, a video posted before the ...

Jan. 28, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data ...